How can we increase the efficacy of vaccines used to protect against viral respiratory diseases such as influenza and COVID-19? Scientists from Inserm, CNRS and Aix-Marseille Université at the....
A large part of the population has developed immunity against SARS-CoV-2 following infection, vaccination – or both. In addition, some infected patients enjoy "hybrid" immunity when they are vaccinated....
ANRS
rf.srna@noitamrofni
Inserm
rf.mresni@esserp
Département communication et information scientifique – rf.srna@noitamrofni